Restricted accessResearch articleFirst published online 2025-12
Program of Genomic Reference and Biobank of the Argentinian Population: A National Initiative for Genomic Equity and Population-Based Research in Argentina
In June 2021, Argentina’s Ministry of Science, Technology, and Innovation launched PoblAr—the Program of Genomic Reference and Biobank of the Argentinian Population. This pioneering initiative aims to generate representative human genomic data and associated metadata for Argentina, a crucial step toward advancing genomic research and public health in the country. PoblAr addresses a significant knowledge gap in a country with a rich and dynamic history of population admixture, where unique genetic and environmental diversity shape health and disease patterns. As one of Latin America’s first large-scale genomic initiatives, PoblAr aligns with similar efforts in Mexico and Brazil, reinforcing its regional and global relevance. The program’s comprehensive sampling protocols integrate biological and nonbiological traits, enabling a multidimensional biobank designed to identify statistical risk factors across diverse conditions. A robust ethical framework underpins PoblAr, prioritizing donor safety, data confidentiality, and equitable community benefits through rigorous informed consent and governance tailored to its scale. PoblAr has established a secure data infrastructure using local informatics tools and enforcing strict anonymization protocols through multilevel access controls. Recent studies on local samples reveal that Argentina’s ancestral composition is more complex and nuanced than previously reported. The program places a strong emphasis on community engagement through an exhaustive communication strategy that fosters collaboration with donors, the broader public, and local governments. By promoting data-driven precision health initiatives across Argentina, PoblAr aims to deliver significant societal benefits and encourage inclusivity.
OssaCA, TorresD. Founder and recurrent mutations in BRCA1 and BRCA2 genes in Latin American countries: State of the art and literature review. Oncologist, 2016; 21(7):832–839; doi: 10.1634/theoncologist.2015-0416
2.
Chacón-DuqueJ-C, AdhikariK, Fuentes-GuajardoM, et al.Latin Americans show wide-spread Converso ancestry and imprint of local Native ancestry on physical appearance. Nat Commun, 2018; 9(1):5388; doi: 10.1038/s41467-018-07748-z
3.
BoekstegersF, SchererD, Barahona PonceC, et al.Development and internal validation of a multifactorial risk prediction model for gallbladder cancer in a high-incidence country. Int J Cancer, 2023; 153(6):1151–1161; doi: 10.1002/ijc.34607
4.
RetamalesJ, Daneri-NavarroA, ArtagaveytiaN, et al.; Latin American Cancer Research Network (LACRN). Implementing standard diagnosis and treatment for locally advanced breast cancer through global research in Latin America: Results from a multicountry pragmatic trial. JCO Glob Oncol, 2024; 10:e2300216; doi: 10.1200/GO.23.00216
5.
Ruiz-LinaresA, AdhikariK, Acuña-AlonzoV, et al.Admixture in Latin America: Geographic structure, phenotypic diversity and self-perception of ancestry based on 7,342 individuals. PLoS Genet, 2014; 10(9):e1004572; doi: 10.1371/journal.pgen.1004572
6.
NorrisET, WangL, ConleyAB, et al.Genetic ancestry, admixture and health determinants in Latin America. BMC Genomics, 2018; 19(S8):861; doi: 10.1186/s12864-018-5195-7
7.
SohailM, Palma-MartínezMJ, ChongAY, et al.Mexican Biobank advances population and medical genomics of diverse ancestries. Nature, 2023; 622(7984):775–783; doi: 10.1038/s41586-023-06560-0
8.
FaundesV, RepettoGM, ValdiviaLE. Discovery of novel genetic syndromes in Latin America: Opportunities and challenges. Genet Mol Biol, 2024; 47(Suppl 1):e20230318; doi: 10.1590/1678-4685-GMB-2023-0318
9.
ButtersA, ThomsonK, HarringtonF, et al.A rare splice-site variant in TNNT2: The need for ancestral diversity in genomic reference data sets. Eur Heart J, 2025; 46(15):1446–1449; doi: 10.1093/eurheartj/ehaf001
10.
DalmassoMC, de RojasI, OlivarN, et al.The first genome-wide association study in the Argentinian and Chilean populations identifies shared genetics with Europeans in Alzheimer’s disease. Alzheimers Dement, 2024; 20(2):1298–1308; doi: 10.1002/alz.13522
11.
Cardoso-Dos-SantosAC, RealesG, Schuler-FacciniL. Clusters of rare disorders and congenital anomalies in South America. Rev Panam Salud Publica, 2023; 47:e98; doi: 10.26633/RPSP.2023.98
12.
OlmedoL, LunaFJ, ZubrzyckiJ, DopazoH, Pellon-MaisonM. Associations between rs9939609 FTO polymorphism with nutrient and food intake and adherence to dietary patterns in an urban Argentinian population. J Acad Nutr Diet, 2024; 124(7):874–882; doi: 10.1016/j.jand.2024.01.001
13.
LleraAS, AbdelhayESFW, ArtagaveytiaN, et al.; United States-Latin American Cancer Research Network (US-LACRN). The transcriptomic portrait of locally advanced breast cancer and its prognostic value in a multi-country cohort of Latin American patients. Front Oncol, 2022; 12:835626; doi: 10.3389/fonc.2022.835626
14.
Alves da QuintaD, RochaD, RetamalesJ, et al.; LACRN Investigators. Closing the gap: Prognostic and predictive biomarker validation for personalized care in a Latin American hormone-dependent breast cancer cohort. Oncologist, 2024; 29(12):e1701–e1713.
15.
DutilJ, GolubevaVA, Pacheco-TorresAL, Diaz-ZabalaHJ, MattaJL, MonteiroAN. The spectrum of BRCA1 and BRCA2 alleles in Latin America and the Caribbean: A clinical perspective. Breast Cancer Res Treat, 2015; 154(3):441–453.
16.
HerzogJS, Chavarri-GuerraY, CastilloD, et al.Genetic epidemiology of BRCA1- and BRCA2-associated cancer across Latin America. NPJ Breast Cancer, 2021; 7(1):107; doi: 10.1038/s41523-021-00319-3
17.
MarkerKM, ZavalaVA, VidaurreT, et al.; COLUMBUS Consortium. Human epidermal growth factor receptor 2–positive breast cancer is associated with Indigenous American ancestry in Latin American women. Cancer Res, 2020; 80(9):1893–1901; doi: 10.1158/0008-5472.CAN-19-3458
18.
WuM, DavisJD, ZhaoC, DaleyT, OliverKE. Racial inequities and rare CFTR variants: Impact on cystic fibrosis diagnosis and treatment. J Clin Transl Endocrinol, 2024; 36:100344; doi: 10.1016/j.jcte.2024.100344
19.
BuuMC, SandersLM, MayoJA, MillaCE, WisePH. Assessing differences in mortality rates and risk factors between hispanic and non-hispanic patients with cystic fibrosis in California. Chest, 2016; 149(2):380–389; doi: 10.1378/chest.14-2189
20.
Claudio-CamposK, DucongeJ, CadillaCL, RuañoG. Pharmacogenetics of drug-metabolizing enzymes in US Hispanics. Drug Metab Pers Ther, 2015; 30(2):87–105; doi: 10.1515/dmdi-2014-0023
21.
PaschettaC, de AzevedoS, RamalloV, et al.The impact of socioeconomic and phenotypic traits on self-perception of ethnicity in Latin America. Sci Rep, 2021; 11(1):12617; doi: 10.1038/s41598-021-92061-x
22.
SchaidDJ, McDonnellSK, AkhtariFS, et al.Polygenic scores and social determinants of health: Their correlations and potential biases. HGG Adv, 2025; 6(1):100389.
World Health Organization (WHO). Guidance for Human Genome Data Collection, Access, Use and Sharing. WHO: Geneva; 2024. Licence: CC BY-NC-SA 3.0 IGO.
27.
Pan American Health Organization (PAHO). Human genomics for health: Enhancing the impact of effective research. Report of the first regional meeting for the Americas. Brasília; 2024 May 15–16. Report No.: PAHO/EIH/SK/24-0007.
28.
DopazoH, LleraA, BerensteinM, et al.enfermedades y medicina de precisión: Un Proyecto Nacional. Cienc Tecnol Polít, 2019; 2(2):19; doi: 10.24215/26183188e019
29.
LuisiP, GarcíaA, BerrosJM, et al.Fine-scale genomic analyses of admixed individuals reveal unrecognized genetic ancestry components in Argentina. PLoS One, 2020; 15(7):e0233808; doi: 10.1371/journal.pone.0233808
30.
De SouzaYG, GreenspanJS. Biobanking past, present and future: Responsibilities and benefits. AIDS, 2013; 27(3):303–312; doi: 10.1097/QAD.0b013e32835c1244
31.
Organization for Economic Cooperation and Development (OECD). Biological Resource Centres: Underpinning the Future of Life Sciences and Biotechnology. Organization for Economic Cooperation and Development (OECD); 2001.
32.
Organization for Economic Cooperation and Development (OECD). Principles and Guidelines for Access to Genetic Resources and Benefit-Sharing. Organization for Economic Cooperation and Development (OECD); 2007.
33.
International Society for Biological and Environmental Repositories (ISBER). Best Practices for Repositories: Collection, Storage, Retrieval and Distribution of Biological Materials for Research. Fifth Edition, International Society for Biological and Environmental Repositories (ISBER); 2023.
BycroftC, FreemanC, PetkovaD, et al.The UK Biobank resource with deep phenotyping and genomic data. Nature, 2018; 562(7726):203–209; doi: 10.1038/s41586-018-0579-z
37.
ElliottLT, SharpK, Alfaro-AlmagroF, et al.Genome-wide association studies of brain imaging phenotypes in UK Biobank. Nature, 2018; 562(7726):210–216; doi: 10.1038/s41586-018-0571-7
38.
BahcallOG. UK Biobank — a new era in genomic medicine. Nat Rev Genet, 2018; 19(12):737; doi: 10.1038/s41576-018-0065-3
39.
RudermanA, LuisiP, PaschettaC, et al.Genetic and self-perceived ancestries in Argentina: Beyond the three-hybrid model. Am J Biol Anthropol, 2023; 181(1):85–95; doi: 10.1002/ajpa.24702
40.
CorpasM, PiusM, PoburennayaM, et al.Bridging genomics’ greatest challenge: The diversity gap. Cell Genom, 2025; 5(1):100724; doi: 10.1016/j.xgen.2024.100724
41.
Organization for Economic Cooperation and Development (OECD).. Development Co-operation Report; 2009.
42.
Council for International Organizations of Medical Sciences. International Ethical Guidelines for Health-Related Research Involving Humans. Council for International Organizations of Medical Sciences; 2016.
43.
World Medical Association. Declaration of Helsinki: Ethical Principles for Medical Research Involving Human Participants. JAMA., 2025; 333(1):71–74.
TindanaP, de VriesJ. Broad consent for genomic research and biobanking: Perspectives from low- and middle-income countries. Annu Rev Genomics Hum Genet, 2016; 17:375–393; doi: 10.1146/annurev-genom-083115-022456
46.
GradyC, EcksteinL, BerkmanB, et al.Broad consent for research with biological samples: Workshop conclusions. Am J Bioeth, 2015; 15(9):34–42.
47.
MuzzioM, MottiJM, Paz SepulvedaPB, et al.Population structure in Argentina. PLoS One, 2018; 13(5):e0196325.
48.
AutonA, BrooksLD, DurbinRM, et al.; 1000 Genomes Project Consortium. A global reference for human genetic variation. Nature, 2015; 526(7571):68–74; doi: 10.1038/nature15393
49.
RamaswamiR, BayerR, GaleaS. Precision medicine from a public health perspective. Annu Rev Public Health, 2018; 39:153–168.
50.
HalleyMC, SmithHS, AshleyEA, et al.A call for an integrated approach to improve efficiency, equity and sustainability in rare disease research in the United States. Nat Genet., 2022; 54(3):219–222.
51.
DavisMB. Genomics and cancer disparities: The justice and power of inclusion. Cancer Discov, 2021; 11(4):805–809.
Supplementary Material
Please find the following supplemental material available below.
For Open Access articles published under a Creative Commons License, all supplemental material carries the same license as the article it is associated with.
For non-Open Access articles published, all supplemental material carries a non-exclusive license, and permission requests for re-use of supplemental material or any part of supplemental material shall be sent directly to the copyright owner as specified in the copyright notice associated with the article.
